These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 36114749)

  • 21. Reduced N6-Methyladenosine Mediated by METTL3 Acetylation Promotes MTF1 Expression and Hepatocellular Carcinoma Cell Growth.
    Yang Y; Qian Cai Q; Sheng Fu L; Wei Dong Y; Fan F; Zhong Wu X
    Chem Biodivers; 2022 Nov; 19(11):e202200333. PubMed ID: 36149370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism.
    Xie W; Ma LL; Xu YQ; Wang BH; Li SM
    Biochem Biophys Res Commun; 2019 Oct; 518(1):120-126. PubMed ID: 31405565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The m6A methyltransferase METTL3 promotes osteosarcoma progression by regulating the m6A level of LEF1.
    Miao W; Chen J; Jia L; Ma J; Song D
    Biochem Biophys Res Commun; 2019 Aug; 516(3):719-725. PubMed ID: 31253399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ZBTB7C m6A modification incurred by METTL3 aberration promotes osteosarcoma progression.
    An X; Wu W; Yang L; Dong J; Liu B; Guo J; Chen J; Guo B; Cao W; Jiang Q
    Transl Res; 2023 Sep; 259():62-71. PubMed ID: 37121538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. METTL3 potentiates progression of cervical cancer by suppressing ER stress via regulating m6A modification of TXNDC5 mRNA.
    Du QY; Huo FC; Du WQ; Sun XL; Jiang X; Zhang LS; Pei DS
    Oncogene; 2022 Sep; 41(39):4420-4432. PubMed ID: 35987795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. METTL3 promotes the malignancy of non-small cell lung cancer by N6-methyladenosine modifying SFRP2.
    Zhao S; Song P; Zhou G; Zhang D; Hu Y
    Cancer Gene Ther; 2023 Aug; 30(8):1094-1104. PubMed ID: 37106069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. METTL3-mediated m6A modification is required for cerebellar development.
    Wang CX; Cui GS; Liu X; Xu K; Wang M; Zhang XX; Jiang LY; Li A; Yang Y; Lai WY; Sun BF; Jiang GB; Wang HL; Tong WM; Li W; Wang XJ; Yang YG; Zhou Q
    PLoS Biol; 2018 Jun; 16(6):e2004880. PubMed ID: 29879109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. JNK Signaling Promotes Bladder Cancer Immune Escape by Regulating METTL3-Mediated m6A Modification of PD-L1 mRNA.
    Ni Z; Sun P; Zheng J; Wu M; Yang C; Cheng M; Yin M; Cui C; Wang G; Yuan L; Gao Q; Li Y
    Cancer Res; 2022 May; 82(9):1789-1802. PubMed ID: 35502544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-HIV Drug Elvitegravir Suppresses Cancer Metastasis via Increased Proteasomal Degradation of m6A Methyltransferase METTL3.
    Liao L; He Y; Li SJ; Zhang GG; Yu W; Yang J; Huang ZJ; Zheng CC; He QY; Li Y; Li B
    Cancer Res; 2022 Jul; 82(13):2444-2457. PubMed ID: 35507004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IL-18 serves as a main effector of CAF-derived METTL3 against immunosuppression of NSCLC via driving NF-κB pathway.
    Xu L; Li K; Li J; Xu F; Liang S; Kong Y; Chen B
    Epigenetics; 2023 Dec; 18(1):2265625. PubMed ID: 37871286
    [No Abstract]   [Full Text] [Related]  

  • 31. HBXIP promotes gastric cancer
    Yang Z; Jiang X; Li D; Jiang X
    Aging (Albany NY); 2020 Oct; 12(24):24967-24982. PubMed ID: 33048840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. METTL3-mediated m6A modification of STEAP2 mRNA inhibits papillary thyroid cancer progress by blocking the Hedgehog signaling pathway and epithelial-to-mesenchymal transition.
    Zhu Y; Peng X; Zhou Q; Tan L; Zhang C; Lin S; Long M
    Cell Death Dis; 2022 Apr; 13(4):358. PubMed ID: 35436987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. METTL3-Mediated m6A Modification Controls Splicing Factor Abundance and Contributes to Aggressive CLL.
    Wu Y; Jin M; Fernandez M; Hart KL; Liao A; Ge X; Fernandes SM; McDonald T; Chen Z; Röth D; Ghoda LY; Marcucci G; Kalkum M; Pillai RK; Danilov AV; Li JJ; Chen J; Brown JR; Rosen ST; Siddiqi T; Wang L
    Blood Cancer Discov; 2023 May; 4(3):228-245. PubMed ID: 37067905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. METTL3 promotes pancreatic cancer proliferation and stemness by increasing stability of ID2 mRNA in a m6A-dependent manner.
    Chen J; Zhang H; Xiu C; Gao C; Wu S; Bai J; Shen Q; Yin T
    Cancer Lett; 2023 Jul; 565():216222. PubMed ID: 37196908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. M6A regulator expression patterns predict the immune microenvironment and prognosis of non-small cell lung cancer.
    Liu X; Ma C; Liu H; Sun Z; Luo J
    J Cancer Res Clin Oncol; 2022 Oct; 148(10):2803-2814. PubMed ID: 35596010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SRSF9 promotes colorectal cancer progression via stabilizing DSN1 mRNA in an m6A-related manner.
    Wang X; Lu X; Wang P; Chen Q; Xiong L; Tang M; Hong C; Lin X; Shi K; Liang L; Lin J
    J Transl Med; 2022 May; 20(1):198. PubMed ID: 35509101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase.
    Ping XL; Sun BF; Wang L; Xiao W; Yang X; Wang WJ; Adhikari S; Shi Y; Lv Y; Chen YS; Zhao X; Li A; Yang Y; Dahal U; Lou XM; Liu X; Huang J; Yuan WP; Zhu XF; Cheng T; Zhao YL; Wang X; Rendtlew Danielsen JM; Liu F; Yang YG
    Cell Res; 2014 Feb; 24(2):177-89. PubMed ID: 24407421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methyltransferase-like 3 leads to lung injury by up-regulation of interleukin 24 through N6-methyladenosine-dependent mRNA stability and translation efficiency in mice exposed to fine particulate matter 2.5.
    He X; Zhang L; Liu S; Wang J; Liu Y; Xiong A; Jiang M; Luo L; Ying X; Li G
    Environ Pollut; 2022 Sep; 308():119607. PubMed ID: 35718042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting METTL3 enhances the chemosensitivity of non-small cell lung cancer cells by decreasing ABCC2 expression in an m
    Zhang R; Chen P; Wang Y; Zeng Z; Yang H; Li M; Liu X; Yu W; Hou P
    Int J Biol Sci; 2024; 20(12):4750-4766. PubMed ID: 39309428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N6-methyladenosine METTL3 promotes the breast cancer progression via targeting Bcl-2.
    Wang H; Xu B; Shi J
    Gene; 2020 Jan; 722():144076. PubMed ID: 31454538
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.